tetrachloroisophthalonitrile has been researched along with Brugada Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Behr, E; Chen, SA; Chung, FP; Das, MK; Haissaguerre, M; Hocini, M; Jan Smit, J; Jiang, C; Khongphatthanayothin, A; Morishima, I; Nademanee, K; Nakagawa, H; Nogami, A; Sacher, F; Sakamoto, Y; Vardhanabhuti, S; Veerakul, G; Wilde, AAM; Yamashiro, K | 1 |
| Imamura, T; Kataoka, N; Kinugawa, K | 1 |
2 other study(ies) available for tetrachloroisophthalonitrile and Brugada Syndrome
| Article | Year |
|---|---|
Long-Term Outcomes of Brugada Substrate Ablation: A Report from BRAVO (Brugada Ablation of VF Substrate Ongoing Multicenter Registry).
Topics: Adult; Brugada Syndrome; Catheter Ablation; Defibrillators, Implantable; Electrocardiography; Heart Ventricles; Humans; Male; Registries; Ventricular Fibrillation | 2023 |
Letter by Kataoka et al Regarding Article, "Long-Term Outcomes of Brugada Substrate Ablation: A Report From BRAVO (Brugada Ablation of VF Substrate Ongoing Multicenter Registry)".
Topics: Brugada Syndrome; Catheter Ablation; Electrocardiography; Epicardial Mapping; Humans; Longitudinal Studies; Registries; Ventricular Fibrillation | 2023 |